Jade Therapeutics Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $2.91M

Jade Therapeutics General Information

Description

Developer of polymer-based pharmaceutical products to treat eye diseases. The company is focused on development of ocular therapeutics that improves corneal healing following damage from disease or injury.

Contact Information

Formerly Known As
iTherapeutics
Ownership Status
Acquired/Merged
Financing Status
Formerly Angel backed
Primary Industry
Pharmaceuticals
Primary Office
  • 675 Arapeen Drive
  • Suite 302
  • Salt Lake City, UT 84108
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jade Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 07-Mar-2016 $2.91M 00.000 Completed Startup
3. Seed Round 01-Jan-2015 Completed Startup
2. Grant 01-Dec-2014 $725K Completed Startup
1. Grant 01-Jan-2013 $150K Completed Startup
To view Jade Therapeutics’s complete valuation and funding history, request access »

Jade Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of polymer-based pharmaceutical products to treat eye diseases. The company is focused on development of ocula
Pharmaceuticals
Salt Lake City, UT
0.000 0000-00-00
000000&0

000000

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
000000000000000
Tarrytown, NY
00000 As of 0000
00.000
000000000000 00.000

000000

uis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu f
000000000000000
Princeton, NJ
000 As of 0000
00000
0000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Jade Therapeutics Competitors (33)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regeneron Pharmaceuticals Formerly VC-backed Tarrytown, NY 00000 00.000 000000000000 00.000
000000 00000 Corporate Backed or Acquired Princeton, NJ 000 00000 000000&0 00000
000000000 00000000 Formerly VC-backed Alpharetta, GA 00 00000 000000000 00000
0000000 Venture Capital-Backed Cambridge, United Kingdom 00 00.000 00000000000 00.000
000000 000 Formerly VC-backed Cranbury, NJ 000 00000 000000&0 00000
You’re viewing 5 of 33 competitors. Get the full list »

Jade Therapeutics Patents

Jade Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9782345-B2 Ocular composition and method Active 17-Oct-2013 0000000000 00
US-20150157563-A1 Ocular composition and method Active 17-Oct-2013 0000000000
EP-2838511-B1 Ocular drug delivery system Inactive 16-Apr-2012 000000000
EP-2838511-A1 Ocular drug delivery system Active 16-Apr-2012 000000000
EP-2838511-A4 Ocular drug delivery system Active 16-Apr-2012 A61K45/06 0
To view Jade Therapeutics’s complete patent history, request access »

Jade Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Barbara Wirostko MD Chief Scientific Officer, Co-Founder & Board Member
You’re viewing 1 of 2 executive team members. Get the full list »

Jade Therapeutics Board Members (2)

Name Representing Role Since
Barbara Wirostko MD Jade Therapeutics Chief Scientific Officer, Co-Founder & Board Member 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Jade Therapeutics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Science Foundation Government 000 0000 000000 0
Salt Lake Life Science Angels Angel Group 000 0000 000000 0
To view Jade Therapeutics’s complete investors history, request access »